These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16998571)

  • 21. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
    van den Bemt BJ; Benraad HB; Rasker JJ
    Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the perioperative phase in traumatology and orthopedics effects on bone healing.
    Beck A; Salem K; Krischak G; Kinzl L; Bischoff M; Schmelz A
    Oper Orthop Traumatol; 2005 Dec; 17(6):569-78. PubMed ID: 16369754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug safety of NSAIDs and COX-2 inhibitors].
    Herdegen T; Fauler J
    Med Monatsschr Pharm; 2006 Apr; 29(4):122-8. PubMed ID: 16628961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
    Coruzzi G; Venturi N; Spaggiari S
    Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?
    Barozzi N; Tett SE
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1184-91. PubMed ID: 17636557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appropriate use of NSAIDs: considering cardiovascular risk in the elderly.
    Stillman MJ; Stillman MT
    Geriatrics; 2007 Mar; 62(3):16-21. PubMed ID: 17346094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Jones R; Rubin G; Berenbaum F; Scheiman J
    Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative pain management after craniotomy: evaluation and cost analysis.
    Rahimi SY; Vender JR; Macomson SD; French A; Smith JR; Alleyne CH
    Neurosurgery; 2006 Oct; 59(4):852-7; discussion 857. PubMed ID: 17038949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of perioperative non-steroidal anti-inflammatory drug treatment.
    Camu F; Vanlersberghe C; Lauwers MH
    Acta Anaesthesiol Belg; 1996; 47(3):125-8. PubMed ID: 8959197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk/benefit evaluation of NSAIDs in postoperative pain therapy.
    Nuutinen LS
    Acta Anaesthesiol Belg; 1996; 47(3):129-33. PubMed ID: 8959198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetaminophen or NSAIDs for the treatment of osteoarthritis.
    Bannwarth B
    Best Pract Res Clin Rheumatol; 2006 Feb; 20(1):117-29. PubMed ID: 16483911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Making progress in the management of postoperative pain: a review of the cyclooxygenase 2-specific inhibitors.
    Stephens JM; Pashos CL; Haider S; Wong JM
    Pharmacotherapy; 2004 Dec; 24(12):1714-31. PubMed ID: 15585440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly. A clinical use pathway.
    Stillman MJ; Stillman MT
    Geriatrics; 2007 Feb; 62(2):26-34. PubMed ID: 17291140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective cyclooxygenase inhibition: its role in pain and anaesthesia.
    Langford RM; Mehta V
    Biomed Pharmacother; 2006 Aug; 60(7):323-8. PubMed ID: 16837162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Perioperative anti-inflammatory drug use: which evidences for their utility and safety?].
    Marret E; Bonnet F
    Ann Fr Anesth Reanim; 2007 Jun; 26(6):535-9. PubMed ID: 17524603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? Arguments in favor.
    Mukherjee D
    Thromb Haemost; 2006 Oct; 96(4):407-12. PubMed ID: 17003915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis.
    Inotai A; Mészáros A
    Int J Technol Assess Health Care; 2009 Apr; 25(2):190-5. PubMed ID: 19366498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
    Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsteroidal gastropathy in dentistry--issues and controversies in patient's management.
    Afolabi AO; Adekanle OA
    Niger J Med; 2009; 18(1):39-42. PubMed ID: 19485146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing new users of NSAIDs before and after rofecoxib withdrawal.
    Usher C; Bennett K; Teeling M; Feely J
    Br J Clin Pharmacol; 2007 Apr; 63(4):494-7. PubMed ID: 17054665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.